Literature DB >> 28455320

CHA2DS2-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study.

Tae-Hoon Kim1, Pil-Sung Yang1, Jae-Sun Uhm1, Jong-Youn Kim1, Hui-Nam Pak1, Moon-Hyoung Lee1, Boyoung Joung2, Gregory Y H Lip2.   

Abstract

BACKGROUND AND
PURPOSE: The CHA2DS2-VASc stroke score (congestive heart failure, hypertension, age ≥75 (doubled), diabetes mellitus, prior stroke or transient ischemic attack (doubled), vascular disease, age 65-74, female) is used in most guidelines for risk stratification in atrial fibrillation (AF), but most data for this score have been derived in Western populations. Ethnic differences in stroke risk may be present. Our objective was to investigate risk factors for stroke in AF and application of the CHA2DS2-VASc score in an Asian AF population from Korea.
METHODS: A total of 5855 oral anticoagulant-naive nonvalvular AF patients aged ≥20 years were enrolled from Korea National Health Insurance Service Sample cohort from 2002 to 2008 and were followed up until December 2013.
RESULTS: The incidence rates (per 100 person-years) of ischemic stroke were 3.32 in the total population, being 0.23 in low-risk (CHA2DS2-VASc score 0 [male] or 1 [female]) and 4.59 in high-risk patients (CHA2DS2-VASc ≥2). Incidence rates of ischemic stroke or the composite thromboembolism end point showed a clear increase with increasing CHA2DS2-VASc score. On multivariable analysis, significant associations between CHA2DS2-VASc risk factors and ischemic stroke were observed; however, the significance of vascular disease or diabetes mellitus was attenuated after multivariate adjustment, and female sex (hazard ratio, 0.73; 95% confidence interval, 0.64-0.84) had a lower risk of ischemic stroke than males. Patients who were categorized as low risk consistently had an event rate <1% per year.
CONCLUSIONS: The performance of CHA2DS2-VASc score in Asians is comparable with that in Western populations. The score shows good performance in defining the truly-low-risk AF patients for stroke/thromboembolism.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  Korea; atrial fibrillation; death; stroke; thromboembolism

Mesh:

Year:  2017        PMID: 28455320     DOI: 10.1161/STROKEAHA.117.016926

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  39 in total

1.  Dynamic stroke risk scores of atrial fibrillation.

Authors:  Minjae Yoon; Boyoung Joung
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

2.  Association of Rivaroxaban vs Apixaban With Major Ischemic or Hemorrhagic Events in Patients With Atrial Fibrillation.

Authors:  Wayne A Ray; Cecilia P Chung; C Michael Stein; Walter Smalley; Eli Zimmerman; William D Dupont; Adriana M Hung; James R Daugherty; Alyson Dickson; Katherine T Murray
Journal:  JAMA       Date:  2021-12-21       Impact factor: 157.335

3.  Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.

Authors:  Sola Han; Hae Sun Suh; Myung-Yong Lee; Oh Young Bang; Young Keun On; Sung-Won Jang; Seongwook Han; Jaeyun Ryu; Yoo-Jung Park; Seongsik Kang; Young-Hoon Kim
Journal:  Adv Ther       Date:  2022-05-07       Impact factor: 4.070

4.  A Simple Clinical Risk Score (C2HEST) for Predicting Incident Atrial Fibrillation in Asian Subjects: Derivation in 471,446 Chinese Subjects, With Internal Validation and External Application in 451,199 Korean Subjects.

Authors:  Yan-Guang Li; Daniele Pastori; Alessio Farcomeni; Pil-Sung Yang; Eunsun Jang; Boyoung Joung; Yu-Tang Wang; Yu-Tao Guo; Gregory Y H Lip
Journal:  Chest       Date:  2018-10-04       Impact factor: 9.410

Review 5.  Efficacy and safety of oral anticoagulants in atrial fibrillation patients with cancer-a network meta-analysis.

Authors:  Pingping Yang; Dan Zhu; Xiuxiu Xu; Wen Shen; Chenxi Wang; Yu Jiang; Gaosi Xu; Qinghua Wu
Journal:  Heart Fail Rev       Date:  2020-09       Impact factor: 4.214

6.  A Prospective Survey of Atrial Fibrillation Management for Real-world Guideline Adherence: COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) Registry.

Authors:  Hyeongsoo Kim; Tae Hoon Kim; Myung Jin Cha; Jung Myung Lee; Junbeom Park; Jin Kyu Park; Ki Woon Kang; Jaemin Shim; Jae Sun Uhm; Jun Kim; Hyung Wook Park; Eue Keun Choi; Jin Bae Kim; Changsoo Kim; Young Soo Lee; Boyoung Joung
Journal:  Korean Circ J       Date:  2017-10-17       Impact factor: 3.243

Review 7.  Real-world Data and Recommended Dosage of Non-vitamin K Oral Anticoagulants for Korean Patients.

Authors:  Boyoung Joung
Journal:  Korean Circ J       Date:  2017-10-17       Impact factor: 3.243

8.  Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer.

Authors:  Kyu Kim; Yong Joon Lee; Tae Hoon Kim; Jae Sun Uhm; Hui Nam Pak; Moon Hyoung Lee; Boyoung Joung
Journal:  Korean Circ J       Date:  2018-02-26       Impact factor: 3.243

Review 9.  Cardiovascular Research Using the Korean National Health Information Database.

Authors:  Eue Keun Choi
Journal:  Korean Circ J       Date:  2020-05-20       Impact factor: 3.243

10.  Variations of Prevalence and Incidence of Atrial Fibrillation and Oral Anticoagulation Rate According to Different Analysis Approaches.

Authors:  Pil-Sung Yang; Soorack Ryu; Daehoon Kim; Eunsun Jang; Hee Tae Yu; Tae-Hoon Kim; Jinseub Hwang; Boyoung Joung; Gregory Y H Lip
Journal:  Sci Rep       Date:  2018-05-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.